According to Amylyx Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -โฌ0.14 B. In 2023 the company made an earning of โฌ35.01 M an increase over its 2022 earnings that were of -โฌ0.19 B.The earnings displayed on this page is the company's Pretax Income.